ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, announced several updates to its PressureWire™ platform, including a new marketing agreement with Siemens Medical Solutions USA, for the wireless PressureWire™ Aeris and the availability of the next-generation of PressureWire™ Certus technology, at the American College of Cardiology (ACC) and the Society of Interventional Radiology (SIR) annual meetings. The enhanced capabilities make the company’s leading Fractional Flow Reserve (FFR) measurement technology, which aids in the diagnosis and treatment of coronary artery blockages, more versatile and accessible for physicians around the world.
